Head and Neck Neoplasms: all 2,403 studies

Page 18 of 25. Open to participants first (559), then studies with results posted, then the rest; newest registration first within each.

• Pre-habilitation of Patients With Head and Neck CancerCompletedNCT02385929Not applicable
• Comparison of Tumor Glucose Metabolism Before and After Artificial NutritionCompletedNCT02382237Not applicable
• Safety Study of SEA-CD40 in Cancer PatientsTerminatedNCT02376699Phase 1
• PCA062 in pCAD-positive Tumors.CompletedNCT02375958Phase 1
• Validation of High-resolution PET/CT for the Pretherapeutic Lymphnode Staging of Head/Neck CancerCompletedNCT02372890
• Safety Study of Musculoskeletal Ultrasonographic to Assess Disabilities Arm of Head and Neck Cancer PatientCompletedNCT02369276
• Efficacy and Safety of Ultrasound Hyperthermia Combined With Chemotherapy on Oral and Maxillofacial-Head and Neck CancerStatus unknownNCT02353260Phase 2
• Molecular Imaging-based Dose Escalation in HPV Negative Patients With Locally Advanced SCC of the OropharynxStatus unknownNCT02336711Not applicable
• Irreversible Electroporation(IRE) For Unresectable Head and Neck NeoplasmsCompletedNCT02335112Not applicable
• Prevalence of Malignant and Premalignant Lesions in the Head & Neck in Patients With Chronic Obstructive Pulmonary DiseaseStatus unknownNCT02333812
• Leg Function and ADL After ALT Reconstruction for Head and Neck CancerCompletedNCT02332161
• PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic AgentsTerminatedNCT02325349Phase 2
• Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation TherapyCompletedNCT02324881Not applicable
• Efficacy of EPA-enriched Supplement in Malnourished Head and Neck Cancer Patients Undergone SurgeryCompletedNCT02321631Not applicable
• Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck CancerCompletedNCT02308072Phase 1
• Clinical Trial on the Efficacy and Safety of Chining Decoction in the Treatment of Radiation StomatitisCompletedNCT02303197Phase 3
• Neurological Effects of Acupuncture to Prevent Radiation-induced XerostomiaCompletedNCT02292368Not applicable
• Early Detection of Tumors of the Digestive Tract by Confocal EndomicroscopyCompletedNCT02284802Not applicable
• Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant TumorsStatus unknownNCT02283489Phase 2
• Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing RadiationStatus unknownNCT02282839Phase 3
• Efficacy of Trans-tympanic Injections of a Sodium Thiosulfate Gel to Prevent Cisplatin-induced OtotoxicityTerminatedNCT02281006Phase 2
• Anti-OX40 Antibody in Head and Neck Cancer PatientsCompletedNCT02274155Phase 1
• MRI and PET-CT for Radiotherapy Planning for Head and Neck CancerCompletedNCT02273778Not applicable
• Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT02270814Phase 2
• Brief Intraoperative Electrical Stimulation for Prevention of Shoulder Dysfunction After Oncologic Neck DissectionCompletedNCT02268344Not applicable
• Health and Economic Outcomes of Two Different Follow up Strategies in Effectively Cured Advanced Head and Neck CancerSuspendedNCT02262221Not applicable
• Preemptive Treatment With XONRID to Reduce Radiation Induced Dermatitis in Head and Neck Cancer PatientsCompletedNCT02261181Not applicable
• Exploring the Neuro-Immune Basis of Cancer-Related Fatigue Using Behavioral MeasuresCompletedNCT02255773Not applicable
• Single Dose Escalation Study of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT02254018Phase 1
• Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer PatientsActive, not recruitingNCT02253238Not applicable
• Smoking Cessation in Head and Neck Cancer Patients Receiving Curative Radiation TherapyCompletedNCT02251730Phase 2
• Management Radiodermatitis in Patients With Breast or Head and Neck CancerCompletedNCT02247830Phase 3
• Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung CancerCompletedNCT02245100
• THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESSStatus unknownNCT02241876Phase 4
• The Effect of Norepinephrine and Dopamine on Radial Forearm Free Flap Tissue Oxygen Pressure and Microdialysate Metabolite MeasurementsCompletedNCT02241083Phase 4
• The Effect of Ganoderma on Patients With Head-and-neck CancerStatus unknownNCT02238587Not applicable
• Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and NeckTerminatedNCT02236936Phase 3
• Olaparib and Radiotherapy in Head and Neck CancerActive, not recruitingNCT02229656Phase 1
• Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ RadiosensitizerWithdrawnNCT02216669Phase 1
• Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid TumorsTerminatedNCT02209701Phase 1
• 2 Phase Use Of Educational Materials In Head And Neck Cancer CenterCompletedNCT02204631Not applicable
• Dose Escalation Study With 99mTC - or 186 Re-labelled Humanised Monoclonal Antibody (hMAb) BIWA 4 in Patients With Head and Neck CancerCompletedNCT02204033Phase 1
• A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive CancersCompletedNCT02188563Not applicable
• Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer PatientsTerminatedNCT02183246Phase 3
• Lymph Node Assessment Using Simultaneous 18F-FDG-PET and MRICompletedNCT02180308
• Home-Based Lymphedema Care Program (HBLCP) in Improving Lymphedema Self-Care in Head and Neck Cancer SurvivorsTerminatedNCT02170272Not applicable
• Intensive Nutrition Counselling in Patients With Head and Neck CancerStatus unknownNCT02159508Not applicable
• A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and NeckCompletedNCT02149602
• Effect of the Rehabilitation Effort at Home in Patients With Head and Neck Tumor Treated With Curative IntentCompletedNCT02135185Phase 2
• Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck CancerCompletedNCT02110082Phase 1
• Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck CancerCompletedNCT02107235Phase 1
• Predictive Modelling for Patient Stratification According to Treatment-related Toxicity and Survival After Chemoradiation for Head and Neck CancerCompletedNCT02103010
• A Randomized Comparative Study of a Weekly Versus Every Other Week Nurse Practitioner-led Symptom Management Clinic for Head and Neck Cancer Patients Undergoing Concurrent Chemotherapy and RadiationWithdrawnNCT02085525Not applicable
• Genetically Modified Mesenchymal Stem Cell Theraopeutic Against Head and Neck CancerCompletedNCT02079324Phase 1
• Swallowing Intervention During Radiochemotherapy on Head and Neck CancerCompletedNCT02075385Phase 2
• Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and NeckCompletedNCT02075112Phase 1
• Incidence and Risk Factors of Refeeding SyndromeCompletedNCT02073032
• Photodynamic Therapy With LUZ11 in Advanced Head and Neck CancerStatus unknownNCT02070432Phase 1/2
• A Prospective Longitudinal Cohort Study Looking at the Difference in Carotid Intima-medial Thickness Between Irradiated and Unirradiated Carotid Arteries in Patients With Head and Neck CancerStatus unknownNCT02069964
• Ensuring Communication in Hospice by Oncology Study (ECHO)CompletedNCT02069769Not applicable
• Progressive Resistance Training Program in Head and Neck Cancer PatientsCompletedNCT02068950Not applicable
• Phase II Study of Whole or Partial Parotid Sparing Intensity Modulated Radiotherapy in Patients With Head and Neck CancersStatus unknownNCT02068313
• A Cross-sectional Study Looking at the Effect of Radiotherapy on Carotid Intima-medial Thickness in Head and Neck CancerCompletedNCT02060643
• Observational Study on Biomarkers in Head and Neck Cancer (HNprädBio)CompletedNCT02059668
• Observational Study of Dental Outcomes in Head and Neck Cancer PatientsCompletedNCT02057510
• Intensive Nutritional Counseling in Head-neck Cancer Patients Undergoing RadiotherapyCompletedNCT02055833Not applicable
• Comparison of Percutaneous Image-guided GastrostomiesCompletedNCT02053428Not applicable
• A Study to Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck CancerCompletedNCT02051751Phase 1
• Intranasal Transmucosal Fentanyl Pectin for Breakthrough Cancer Pain in Radiation-induced Oropharyngeal MucositisCompletedNCT02050503
• Investigation of the Role of Human Papilloma Virus (HPV) in the Prognosis of Head and Neck CancerCompletedNCT02049177
• Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related MalignanciesCompletedNCT02048917Phase 1
• After Induction Chemotherapy of DP Plus DDP Concurrent Radiotherapy With and Without Bevacizumab StudyStatus unknownNCT02047487
• Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)TerminatedNCT02045186Not applicable
• Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT02035527Phase 1
• Quick Diagnostic Program for Head and Neck CancerCompletedNCT02030509
• NIR Fluorescence Imaging During Neck Dissection in Head and Neck Cancer Patients After iv Injection of ICGStatus unknownNCT02027831Phase 2
• Study to Evaluate the Natural History of Head and Neck Cancer Precursors in TaiwanCompletedNCT02017288
• Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and NeckTerminatedNCT02015650Phase 4
• A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck CancerWithdrawnNCT02013453Phase 2
• BNCT and IG-IMRT for Recurrent Head and Neck CancerStatus unknownNCT02004795Phase 1/2
• Prospective Trial of Serial CT Imaging for Evaluation of Dosimetric/Volumetric Changes During IMRT for Head/Neck CancerCompletedNCT02003482
• Safety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and NeckCompletedNCT01998542Phase 2
• Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical ProceduresTerminatedNCT01987375Phase 1
• A Trial Comparing Two Modalities of Prophylactic Nutritional Support During Treatment for Head and Neck CancerStatus unknownNCT01985438Not applicable
• HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck CancerCompletedNCT01984359Not applicable
• PEctin Rapid Fentanyl Efficacy Clinical Trial For pAin at Swallowing Undergoing radioTherapyWithdrawnNCT01980498Phase 3
• Mucin Glycosylating Enzymes in Head and Neck CancersStatus unknownNCT01976377
• Ketogenic Diet Phase 1 for Head & Neck CancerTerminatedNCT01975766Not applicable
• Re-irradiation of Recurrent Head and Neck CancerActive, not recruitingNCT01973179
• International Cancer of the Head and Neck, Genetics and Environment (InterCHANGE) StudyStatus unknownNCT01972802
• A Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.CompletedNCT01969877Phase 3
• Parotid-gland Stem-cell Sparing Intensity-modulated RadiotherapyCompletedNCT01955239Not applicable
• Validity and Reliability of Outcome Measures in Patients With Cancer of the Head and NeckCompletedNCT01952821
• Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer SurvivorsCompletedNCT01951664Not applicable
• NBTXR3 and Radiation Therapy in Treating Patients With Locally Advanced SCC of the Oral Cavity or OropharynxStatus unknownNCT01946867Not applicable
• A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck CancersStatus unknownNCT01936376
• Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreated Stage III-IVB Head and Neck CancerCompletedNCT01935921Phase 1
• FACBC for Head and Neck CancersWithdrawnNCT01933269Early Phase 1
• A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & NeckCompletedNCT01921426Phase 1
• Radiotherapy With Humidification in Head And Neck CancerCompletedNCT01917942Phase 3

← Head and Neck Neoplasms overview